FAMILIAL CANCER DISORDERS

For the cancer services listed below the identification of a familial mutation allows at risk family members to request presymptomatic testing.

It is recommended that testing in this laboratory occurs only after appropriate genetic counselling by a Clinical Genetics Unit

Please click on disease for more information:

Birt–Hogg–Dubé

Breast / Ovarian Cancer -hereditary

Carney Stratakis syndrome

Familial Adenomatous Polyposis (FAP)

Familial Platelet Disorder (FPD/AML)

Fumarate Hydratase Deficiency

Gastric cancer

Gorlin syndrome (NBCCS)

Hereditary Leiomyomatosis and Renal Cell Cancer

Hereditary Papillary Renal Carcinoma

Lynch syndrome / Hereditary Non-Polyposis Colorectal Cancer (HNPCC)

Medullary Thyroid Carcinoma

Multiple Cutaneous and Uterine Leiomyomatosis

Multiple Endocrine Neoplasia (MEN 2A & 2B)

MET proto-oncogene analysis

MYH-Associated Polyposis

Paraganglioma / Phaechromocytoma

Peutz Jeghers syndrome

PTEN harmartoma tumour syndrome

Renal Cell Cancer

RET proto-oncogene analysis

von-Hippel Lindau (VHL)

Author: Joanne Mason  Authorised by: Fiona Macdonald Version 1.0.4.4
Authorised on 11/05/2011 Next review date 11/05/2013
ONLY VALID ON DAY OF PRINTING